First Wave BioPharma, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$2.18 | -$2.18 | -$2.18 |
| Q2 2024 | 1 | -$1.00 | -$1.00 | -$1.00 |
| Q3 2024 | 1 | -$0.80 | -$0.80 | -$0.80 |
| Q4 2024 | 1 | -$0.70 | -$0.70 | -$0.70 |
First Wave BioPharma, Inc. Earnings Date And Information
First Wave BioPharma, Inc. last posted its earnings results on Tuesday, May 14th, 2024. The company reported $0.38 earnings per share for the quarter, topping analysts' consensus estimates of $-2.18 by $2.56. The company had revenue of 0 for the quarter and had revenue of 0 for the year. First Wave BioPharma, Inc. has generated $-47 earnings per share over the last year ($-46.96 diluted earnings per share) and currently has a price-to-earnings ratio of -0.85. First Wave BioPharma, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 12th, 2024 based on prior year's report dates.
First Wave BioPharma, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/14/2024 | Q1 2024 | -$2.18 | $3.12 | 5.3 | $0 | $0 |
| 03/29/2024 | Q4 2023 | -$2.63 | $138,768 | |||
| 11/13/2023 | Q3 2023 | -$12.40 | -$9.08 | 3.32 | $0 | |
| 08/14/2023 | Q2 2023 | -$20.80 | -$36.89 | -16.09 | $0 | |
| 05/12/2023 | Q1 2023 | -$2.13 | -$35.85 | -33.72 | $0 | |
| 03/20/2023 | Q4 2022 | $2.90 | -$114.42 | -117.32 | $0 | |
| 11/14/2022 | Q3 2022 | -$421.27 | $19.20 | 440.47 | $0 | |
| 08/15/2022 | Q2 2022 | -$2,101.47 | -$52.10 | 2049.37 | $0 | |
| 05/23/2022 | Q1 2022 | -$1,639.15 | -$133.36 | 1505.79 | $-7,000 | $0 |
| 03/31/2022 | Q4 2021 | -$158.90 | $36.64 | 195.54 | $0 | |
| 11/15/2021 | Q3 2021 | -$3,320.33 | -$683.36 | 2636.97 | $0 | |
| 08/16/2021 | Q2 2021 | -$152.25 | -$249.42 | -97.17 | $0 | |
| 05/24/2021 | Q1 2021 | -$152.25 | -$291.61 | -139.36 | $0 | |
| 03/31/2021 | Q4 2020 | -$285.60 | -$1,285.02 | -999.42 | $0 | |
| 11/16/2020 | Q3 2020 | -$285.60 | -$391.30 | -105.7 | $0 | |
| 08/14/2020 | Q2 2020 | -$222.60 | -$351.99 | -129.39 | $0 | |
| 05/15/2020 | Q1 2020 | -$246.75 | -$410.11 | -163.36 | $2.06 M | |
| 03/30/2020 | Q4 2019 | -$336.00 | -$120.02 | 215.98 | $0 | |
| 11/14/2019 | Q3 2019 | -$330.75 | -$352.72 | -21.97 | $0 | |
| 08/12/2019 | Q2 2019 | -$451.50 | -$517.11 | -65.61 | $0 |
First Wave BioPharma, Inc. Earnings: Frequently Asked Questions
-
When is First Wave BioPharma, Inc.'s earnings date?
First Wave BioPharma, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 12th, 2024 based off last year's report dates.
-
Did First Wave BioPharma, Inc. beat their earnings estimates last quarter?
In the previous quarter, First Wave BioPharma, Inc. (:FWBI) reported $0.38 earnings per share (EPS) to beat the analysts' consensus estimate of $-2.18 by $2.56.
-
How can I listen to First Wave BioPharma, Inc.'s earnings conference call?
The conference call for First Wave BioPharma, Inc.'s latest earnings report can be listened to online.
-
How can I read First Wave BioPharma, Inc.'s conference call transcript?
The conference call transcript for First Wave BioPharma, Inc.'s latest earnings report can be read online.
-
How much profit does First Wave BioPharma, Inc. generate each year?
First Wave BioPharma, Inc. (:FWBI) has a recorded net income of $0. First Wave BioPharma, Inc. has generated $-46.96 earnings per share over the last four quarters.
-
What is First Wave BioPharma, Inc.'s price-to-earnings ratio?
First Wave BioPharma, Inc. (:FWBI) has a price-to-earnings ratio of -0.85 and price/earnings-to-growth ratio is -0.02.
